BPC-157
BPC-157 is a 15-amino-acid research peptide. Selected animal injury studies and a two-person human safety pilot explore different questions; neither establishes treatment benefit for injured patients.
Research topics
Read the studies →
Intestinal function, absorption, and bowel conditions.
This topic groups related research questions. Shared biology does not make different peptides interchangeable, or establish a clinical benefit. Compare each paper’s population, preparation, and measured outcome.
BPC-157 is a 15-amino-acid research peptide. Selected animal injury studies and a two-person human safety pilot explore different questions; neither establishes treatment benefit for injured patients.
Research topics
Read the studies →IGF-1 LR3 is a modified IGF-1 analogue. A rat experiment assessed intestinal tissue growth and glucose-analogue absorption, rather than bodybuilding outcomes.
Research topics
Read the studies →KPV is a three-amino-acid peptide investigated in intestinal and immune-cell research. Its short sequence does not make clinical efficacy self-evident.
Research topics
Read the studies →Lanreotide is a prescription somatostatin analogue used in specific endocrine and neuroendocrine conditions. Its evidence depends on the disease being treated.
Prescription medicines
Read the studies →Larazotide is an investigational peptide studied for persistent symptoms in celiac disease. The featured trial kept participants on a gluten-free diet.
Research topics
Read the studies →Linaclotide is an orally administered peptide medicine for defined constipation conditions. Its clinical outcomes concern bowel function and associated symptoms.
Prescription medicines
Read the studies →Octreotide is a somatostatin-related medicine used in specialist endocrine and gastrointestinal care. Immediate- and long-acting preparations have different roles.
Prescription medicines
Read the studies →Peptide YY is a gut-hormone family involved in feeding regulation. The selected trial studied PYY3-36 alone and with GLP-1; the combined result should not be described as a proven PYY-alone effect.
Research topics
Read the studies →Plecanatide is an oral peptide medicine used for chronic idiopathic constipation and IBS with constipation in adults.
Prescription medicines
Read the studies →Teduglutide is a peptide medicine for short bowel syndrome with dependence on intravenous nutrition or fluids. It acts in a different pathway from GLP-1 medicines.
Prescription medicines
Read the studies →Vasoactive intestinal peptide participates in vascular and immune signaling. A large trial of intravenous aviptadil in COVID-19 respiratory failure did not show a significant improvement in its primary outcome.
Research topics
Read the studies →